✦ LIBER ✦

Three-Year Outcomes From BENEFIT-EXT: A Phase III Study of Belatacept Versus Cyclosporine in Recipients of Extended Criteria Donor Kidneys

✍ Scribed by J. O. Medina Pestana; J. M. Grinyo; Y. Vanrenterghem; T. Becker; J. M. Campistol; S. Florman; V. D. Garcia; N. Kamar; P. Lang; R. C. Manfro; P. Massari; M. D. C. Rial; M. A. Schnitzler; S. Vitko; T. Duan; A. Block; M. B. Harler; A. Durrbach

Book ID: 114806322
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 619 KB
Volume: 12
Category: Article
ISSN: 1600-6135
DOI: 10.1111/j.1600-6143.2011.03914.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Phase III Study of Belatacept Versus C

A Phase III Study of Belatacept Versus Cyclosporine in Kidney Transplants from Extended Criteria Donors (BENEFIT-EXT Study)

✍ A. Durrbach; J. M. Pestana; T. Pearson; F. Vincenti; V. D. Garcia; J. Campistol; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 119 KB

A Phase III Study of Belatacept-based Im

A Phase III Study of Belatacept-based Immunosuppression Regimens versus Cyclosporine in Renal Transplant Recipients (BENEFIT Study)

✍ F. Vincenti; B. Charpentier; Y. Vanrenterghem; L. Rostaing; B. Bresnahan; P. Dar 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 129 KB

Improvement in renal function in kidney

Improvement in renal function in kidney transplant recipients switched from cyclosporine or tacrolimus to belatacept: 2-year results from the long-term extension of a phase II study

✍ Josep Grinyo; Josefina Alberu; Fabiana L. C. Contieri; Roberto C. Manfro; Guille 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 196 KB